Atlas Trials

Steroid Sparing Treatment With in Newly Diagnosed Transplant Ineligible Patients With Multiple Myeloma

Clinical trial NCT04635189 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04635189
Sponsor
University of Rochester
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2021-07-27
Primary completion
2026-07-31
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.